Publications by authors named "C S Cleeland"
Article Synopsis
- - The study aimed to track symptom severity in multiple myeloma (MM) patients during 16 weeks of induction therapy and identify factors that predict high symptom burden, which are often overlooked in clinical settings.
- - Researchers used a symptom inventory to categorize patients into groups with persistently high or low symptom severity, finding that severe symptoms included pain, muscle weakness, and fatigue, affecting patients' quality of life and emotional well-being.
- - Results indicated that 31% of patients experienced high-severity symptoms, with factors like baseline symptom scores and being female linked to worse outcomes, highlighting the need for better monitoring and support during therapy.
Article Synopsis
- * The CSS was developed using five key symptoms (pain, fatigue, shortness of breath, muscle weakness, coughing) identified from the MD Anderson Symptom Inventory for MPM and showed a strong correlation with other established symptom measurement scales.
- * This new score is user-friendly, allowing for frequent electronic administration, making it a valuable tool for assessing symptom changes during clinical trials and improving patient management in practice.
Background: Optimal surgical recovery is critical to readiness to return to intended oncologic therapy (RIOT). The current study defined the value of patient-reported outcomes (PROs) in predicting the risk for delayed RIOT after oncologic hepatic resection.
Methods: In a prospective longitudinal study, perioperative symptoms were assessed using a valid PRO assessment tool, the MD Anderson Symptom Inventory module for hepatectomy perioperative care (MDASI-PeriOp-Hep), for 4 weeks after surgery.
Background: Growing concerns about opioid use disorder (OUD) and the resulting decrease in opioid availability for patients with cancer pain highlight the need for reliable screening tools to identify the subset of patients at increased risk for aberrant opioid use. Our study examines the utility of Current Opioid Misuse Measure (COMM) recommended by the NCCN Clinical Practice Guidelines in Oncology for Adult Cancer Pain.
Patients And Methods: We analyzed prospectively collected patient-reported outcomes of 444 consecutive patients with cancer seen in pain clinics of a cancer center at 2 time points within 100 days.
This is a longitudinal prospective study that tracked multiple symptom burden and functioning status for bladder cancer (BLC) patients for 3 months post-radical cystectomy at The University of Texas MD Anderson Cancer Center, using a validated disease-specific patient-reported outcome measure (PROM) tool, the MD Anderson Symptom Inventory (the MDASI-PeriOp-BLC). The feasibility of collecting an objective measure for physical functioning, using "Timed Up & Go test" (TUGT) and PRO scores at baseline, discharge and end of study, was tested. Patients ( = 52) received care under an ERAS pathway.
View Article and Find Full Text PDF